Androgen deficiency: Association with increased anxiety and depression symptom severity in anorexia nervosa

Journal of Clinical Psychiatry

Volumn 68, Issue 6, 2007, Pages 959-965

  Miller, Karen K ^a   Wexler, Tamara L ^a   Zha, Alicia M ^a   Lawson, Elizabeth A ^a   Meenaghan, Erinne M ^a   Misra, Madhusmita ^a   Binstock, Anna B ^a   Herzog, David B ^a   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; TESTOSTERONE;

ADULT; ANDROGEN DEFICIENCY; ANOREXIA NERVOSA; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE SEVERITY; EATING DISORDER; ENDOCRINE DISEASE; FEMALE; HAMILTON SCALE; HUMAN; HYPOTHESIS; LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

EID: 34347366102     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v68n0621     Document Type: Article

References (28)

1. Braun DL, Sunday SR, Halmi KA. Psychiatric comorbidity in patients with eating disorders. Psychol Med 1994;24:859-867
2. Herzog DB, Keller MB, Sacks NR, et al. Psychiatric comorbidity in treatment-seeking anorexics and bulimics. J Am Acad Child Adolesc Psychiatry 1992;31:810-818
3. Godart NT, Flament MF, Curt F, et al. Anxiety disorders in subjects seeking treatment for eating disorders: a DSM-IV controlled study. Psychiatry Res 2003;117:245-258
4. Kaye WH, Bulik CM, Thornton L, et al. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry 2004;161: 2215-2221
5. Wonderlich SA, Mitchell JE. Eating disorders and comorbidity: empirical, conceptual, and clinical implications. Psychopharmacol Bull 1997; 33:381-390
6. Shores MM, Sloan KL, Matsumoto AM, et al. Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 2004;61:162-167
7. Pope HG Jr, Cohane GH, Kanayama G, et al. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 2003;160:105-111
8. Adler A, Vescovo P, Robinson JK, et al. Gonadectomy in adult life increases tyrosine hydroxylase immunoreactivity in the prefrontal cortex and decreases open field activity in male rats. Neuroscience 1999; 89:939-954
9. Bitran D, Kellogg CK, Hilvers RJ. Treatment with an anabolic-androgenic steroid affects anxiety-related behavior and alters the sensitivity of cortical GABAA receptors in the rat. Horm Behav 1993;27:568-583
10. Fernandez-Guasti A, Martinez-Mota L. Orchidectomy sensitizes male rats to the action of diazepam on burying behavior latency: role of testosterone. Pharmacol Biochem Behav 2003;75:473-479
11. 1983 Metropolitan height and weight tables. Stat Bull Metrop Life Found 1983;64:3-9
12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
13. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55
14. Gamer D. Eating Disorder Inventory-2 Professional Manual. Odessa, Fla: Psychological Assessment Resources; 1991
15. Mond JM, Hay PJ, Rodgers B, et al. Eating Disorder Examination Questionnaire (EDE-Q): norms for young adult women. Behav Res Ther 2006;44:53-62
16. Miller KK, Grieco KA, Klibanski A. Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab 2005;90: 1428-1433
17. Frye CA, Lacey EH. Posttraining androgens' enhancement of cognitive performance is temporally distinct from androgens' increases in affective behavior. Cogn Affect Behav Neurosci 2001;1:172-182
18. Edinger KL, Frye CA. Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Psychoneuroendocrinology 2005;30:418-430
19. Aikey JL, Nyby JG, Anmuth DM, et al. Testosterone rapidly reduces anxiety in male house mice (Mus musculus). Horm Behav 2002;42: 448-460
20. Hermans EJ, Putman P, Baas JM, et al. A single administration of testosterone reduces fear-potentiated startle in humans. Biol Psychiatry 2006; 59:872-874
21. van Honk J, Peper JS, Schutter DJ. Testosterone reduces unconscious fear but not consciously experienced anxiety: implications for the disorders of fear and anxiety. Biol Psychiatry 2005;58:218-225
22. Booth A, Dabbs J. Testosterone and men's marriages. Social Forces 1993;72:463-477
23. Miller KK, Biller BM, Beauregard C, et al. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2006;91:1683-1690
24. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-688
25. Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999;341: 1013-1020
26. Wolkowitz OM, Reus VI, Keebler A, et al. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 1999;156:646-649
27. Hunt PJ, Gurnell EM, Huppert FA, et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 2000;85: 4650-4656
28. Strous RD, Maayan R, Lapidus R, et al. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 2003;60:133-141